Part 3: Ensuring Proper Data Collection
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…
Certara2024 年 10 月 31 日
Part 2: Regulatory Challenges With Data Collection
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…
Certara2024 年 10 月 31 日
Part 1: Complexities in Data Collection
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…
Certara2024 年 10 月 31 日
Mathematical Models can Assist in Broadening use of Immuno-oncology Drugs to Treat Autoimmunity
Connecting Cancer and Autoimmunity "The dosing regimens in oncology may not directly inform the optimal…
Certara2024 年 10 月 31 日
Mathematical Modeling and the Monkey King: Use of Modeling for More Efficient NHP Study Design
Background Monkeys and humans share a strong bond, reflected not only in a shared genetic…
Certara2024 年 10 月 30 日
How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton
In this podcast, Dr. Chris Bouton, Senior VP and Head of AI at Certara, highlights…
Certara2024 年 10 月 30 日
Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women
The article titled "Using PBPK modeling to supplement clinical data and support the safe and…
Certara2024 年 10 月 30 日
The Complete Guide to CDISC Standards Management
Learn how to easily manage and validate against CDISC data standards our complete guide to…
Certara2024 年 10 月 30 日
Certara Announces New Head of Clinical Pharmacology & Translational Medical Group
RADNOR, PA – 2024 年 10 月 30 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2024 年 10 月 30 日
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment
摘要：T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy.…
Certara2024 年 10 月 29 日
